These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34764653)

  • 1. Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population.
    Corredor-Orlandelli D; Sambracos-Parrado S; Mantilla-García S; Tovar-Tirado J; Vega-Ramírez V; Mendoza-Ayús SD; Peña LC; Leal MF; Rodríguez-Carrillo J; León-Torres J; Pardo-Oviedo JM; Parra Abaunza K; Contreras Bravo NC; Ortega-Recalde O; Fonseca Mendoza DJ
    Vasc Health Risk Manag; 2021; 17():689-699. PubMed ID: 34764653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome.
    Peng W; Shi X; Xu X; Lin Y
    Cardiovasc Ther; 2019; 2019():3470145. PubMed ID: 31772608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between clopidogrel resistance and genetic variability in Kawasaki disease children with coronary artery lesions].
    Cao YY; Pan QY; Li J; Zhong XF; Liang XC; He L; Chu C; Zhao QM; Zhao L; Wang F; Sun SN; Lin YX; Huang GY; Liu F
    Zhonghua Er Ke Za Zhi; 2024 Oct; 62(10):981-988. PubMed ID: 39327966
    [No Abstract]   [Full Text] [Related]  

  • 4. PON1 Q192R is associated with high platelet reactivity with clopidogrel in patients undergoing elective neurointervention: A prospective single-center cohort study.
    Tanaka K; Matsumoto S; Ainiding G; Nakahara I; Nishi H; Hashimoto T; Ohta T; Sadamasa N; Ishibashi R; Gomi M; Saka M; Miyata H; Watanabe S; Okata T; Sonoda K; Koge J; Iinuma KM; Furuta K; Nagata I; Matsuo K; Matsushita T; Isobe N; Yamasaki R; Kira JI
    PLoS One; 2021; 16(8):e0254067. PubMed ID: 34351918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.
    Tresukosol D; Suktitipat B; Hunnangkul S; Kamkaew R; Poldee S; Tassaneetrithep B; Likidlilid A
    PLoS One; 2014; 9(10):e110188. PubMed ID: 25329996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
    Sibbing D; Koch W; Massberg S; Byrne RA; Mehilli J; Schulz S; Mayer K; Bernlochner I; Schömig A; Kastrati A
    Eur Heart J; 2011 Jul; 32(13):1605-13. PubMed ID: 21527445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients.
    Yang J; Zhou JS; Tan J; He BS; Zou JJ
    Pharmazie; 2012 Dec; 67(12):1026-9. PubMed ID: 23346768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Fromm MF; Zolk O; Valina CM; Stratz C; Neumann FJ
    Circ Cardiovasc Genet; 2011 Aug; 4(4):429-36. PubMed ID: 21685174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity.
    Li X; Zhang L; Chen X; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Xu Q; Zhang Y; Li Y; Lu C; Yin T
    Thromb Res; 2013 Oct; 132(4):444-9. PubMed ID: 23993903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PON1 genotype and haplotype with susceptibility to coronary artery disease and clinical outcomes in dual antiplatelet-treated Han Chinese patients.
    Kang YH; Lao HY; Wu H; Lai WH; Li XX; Yu XY; Chen JY; Zhong SL
    Eur J Clin Pharmacol; 2013 Aug; 69(8):1511-9. PubMed ID: 23608957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.
    Chen H; Ding S; Zhou M; Wu X; Liu X; Liu J; Wu Y; Liu D
    Herz; 2018 Nov; 43(7):642-648. PubMed ID: 28835968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between PON1 rs662 polymorphism and coronary artery disease.
    Liu T; Zhang X; Zhang J; Liang Z; Cai W; Huang M; Yan C; Zhu Z; Han Y
    Eur J Clin Nutr; 2014 Sep; 68(9):1029-35. PubMed ID: 24918121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.
    Paré G; Ross S; Mehta SR; Yusuf S; Anand SS; Connolly SJ; Fox KA; Eikelboom JW
    Circ Cardiovasc Genet; 2012 Apr; 5(2):250-6. PubMed ID: 22368149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
    Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
    PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.
    Agrawal S; Tripathi G; Prajnya R; Sinha N; Gilmour A; Bush L; Mastana S
    Indian J Med Sci; 2009 Aug; 63(8):335-44. PubMed ID: 19770524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase-1 Q192R polymorphism and its association with hs-CRP and fasting blood glucose levels and risk of coronary artery disease.
    Amini M; Esmaeilzadeh-Bahabadi S; Avan A; Gholoobi A; Ghasemi F; Mirhafez SR; Ghazizadeh H; Moohebati M; Ebrahimi M; Ferns GA; Pasdar A; Mobarhan MG
    Diabetes Metab Syndr; 2019; 13(2):1053-1057. PubMed ID: 31336443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI.
    Park KW; Park JJ; Kang J; Jeon KH; Kang SH; Han JK; Lee SE; Yang HM; Lee HY; Kang HJ; Koo BK; Oh BH; Park YB; Kim HS
    PLoS One; 2013; 8(2):e52779. PubMed ID: 23418418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis.
    Bae SC; Lee YH
    Clin Rheumatol; 2019 Aug; 38(8):2141-2149. PubMed ID: 30868319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.
    Lee YH; Kim JH; Seo YH; Choi SJ; Ji JD; Song GG
    Neurol Sci; 2015 Jan; 36(1):11-20. PubMed ID: 25301263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population.
    Arca M; Ombres D; Montali A; Campagna F; Mangieri E; Tanzilli G; Campa PP; Ricci G; Verna R; Pannitteri G
    Eur J Clin Invest; 2002 Jan; 32(1):9-15. PubMed ID: 11851721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.